Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Daclizumab induction therapy in liver transplant recipients with renal insufficiency.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Daclizumab induction therapy in liver transplant recipients with renal insufficiency.
Daclizumab induction therapy in liver transplant recipients with renal insufficiency. Aliment Pharmacol Ther. 2010 Sep; 32(6):776-86.
View in:
PubMed
subject areas
Adult
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Case-Control Studies
Female
Graft Rejection
Humans
Immunoglobulin G
Immunosuppressive Agents
Liver Diseases
Liver Transplantation
Male
Middle Aged
Renal Insufficiency
Retrospective Studies